umu.sePublications
Change search
ReferencesLink to record
Permanent link

Direct link
New Advances in the Treatment of Metastatic Pancreatic Cancer
Show others and affiliations
2015 (English)In: Digestion, ISSN 0012-2823, E-ISSN 1421-9867, Vol. 92, no 3, 175-184 p.Article, review/survey (Refereed) Published
Abstract [en]

Background: Pancreatic ductal adenocarcinoma (PDAC) is characterised by an extremely poor overall survival (OS) compared to other solid tumours. As the incidence of the disease is rising and the treatment options are limited, PDAC is projected to be the 2nd leading cause of cancer-related deaths in the United States by 2030. A majority of patients are not eligible for curative resection at the time of diagnosis, and those that are resected will often relapse within the first few years after surgery. Summary: Until recently, the nucleoside analogue gemcitabine has been the standard of care for patients with non-resectable PDAC with only marginal effects on OS. In 2011, the gemcitabine-free FOLFIRINOX regimen (folinic acid, fluorouracil, irinotecan and oxaliplatin) showed a significant survival advantage for patients with metastatic PDAC in a phase III trial. In 2013, the Metastatic Pancreatic Adenocarcinoma Trial phase III trial with nano-formulated albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine also resulted in a significant survival extension compared to gemcitabine monotherapy. However, both intensified therapy regimens show a broad spectrum of side effects and patients need to be carefully selected for the most appropriate protocol. Key Message: In this study, recent advances in the chemotherapeutic options available to treat metastatic PDAC and their implications for today's treatment choices are reviewed.

Place, publisher, year, edition, pages
S. Karger, 2015. Vol. 92, no 3, 175-184 p.
Keyword [en]
Chemotherapy, Pancreatic ductal adenocarcinoma, FOLFIRINOX, Nab-paclitaxel, Chemoresistance
National Category
Gastroenterology and Hepatology Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-111170DOI: 10.1159/000439523ISI: 000362928900009OAI: oai:DiVA.org:umu-111170DiVA: diva2:868381
Available from: 2015-11-10 Created: 2015-11-06 Last updated: 2015-11-10Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Sund, Malin
By organisation
Department of Surgical and Perioperative Sciences
In the same journal
Digestion
Gastroenterology and HepatologyCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 24 hits
ReferencesLink to record
Permanent link

Direct link